An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial
Nature.com - 18 Apr 2024An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial ...
phase 2 of omicron response
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial ...
The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level ... - Infectious Diseases of Poverty
BioMed Central - 24 Nov 2022The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level ... ...
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Nature.com - 28 Aug 2023Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial ...
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed ...
ScienceDirect.com - 12 Mar 2024SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed ... ...
Covid-19 NZ: Jacinda Ardern moves New Zealand into phase 2 of Omicron response, shrinking isolation period
Stuff - 14 Feb 2022Covid-19 NZ: Jacinda Ardern moves New Zealand into phase 2 of Omicron response, shrinking isolation period ...
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune ...
Nature.com - 06 Jul 2023SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune ... ...
SARS-CoV-2 variants evolve convergent strategies to remodel the host response
ScienceDirect.com - 12 Oct 2023SARS-CoV-2 variants evolve convergent strategies to remodel the host response ...
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin ...
Nature.com - 18 Aug 2023Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin ... ...
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 ...
ScienceDirect.com - 19 Aug 2022Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 ... ...
Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of ...
Nature.com - 13 Nov 2023Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of ... ...
Comparable safety and non-inferior immunogenicity of the SARS-CoV-2 mRNA vaccine candidate PTX-COVID19-B ...
Nature.com - 04 Mar 2024Comparable safety and non-inferior immunogenicity of the SARS-CoV-2 mRNA vaccine candidate PTX-COVID19-B ... ...
SARS-CoV-2 Omicron variant: recent progress and future perspectives | Signal Transduction and Targeted Therapy
Nature.com - 28 Apr 2022SARS-CoV-2 Omicron variant: recent progress and future perspectives | Signal Transduction and Targeted Therapy ...
Safety and immunogenicity of Ad5-nCoV immunization after three-dose priming with inactivated SARS-CoV-2 vaccine ...
Nature.com - 08 Aug 2023Safety and immunogenicity of Ad5-nCoV immunization after three-dose priming with inactivated SARS-CoV-2 vaccine ... ...
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 ...
Nature.com - 18 Nov 2022Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 ... ...
A two-arm analysis of the immune response to heterologous boosting of inactivated SARS-CoV-2 vaccines | Scientific ...
Nature.com - 31 Oct 2023A two-arm analysis of the immune response to heterologous boosting of inactivated SARS-CoV-2 vaccines | Scientific ... ...
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial
Nature.com - 03 Mar 2022Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial ...
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents ...
Nature.com - 14 Dec 2022Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents ... ...
Antibody response and cross-neutralization after Omicron BA.2 infection | Signal Transduction and Targeted Therapy
Nature.com - 07 Jan 2023Antibody response and cross-neutralization after Omicron BA.2 infection | Signal Transduction and Targeted Therapy ...
Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection | Signal Transduction and ...
Nature.com - 19 Jun 2023Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection | Signal Transduction and ... ...
What's New
- Pope clears way for first millennial saint, dubbed 'God's Influencer'
- Newcastle thrashed 8-0 during post-season tour of Australia - ESPN
- Step-by-step guide to apply for NELFUND student loan
- Examining the legacy of Iran's late president Ebrahim Raisi
- England men's Elite League squad named for June games
- 5 VPN features you need to start using today
- Abba Ya Tabbatar da Korar Aminu Ado Bayero, Ya Sanya Hannu a ...
- Experience the Champions League Final at the Santiago Bernabéu
- UEFA European Football Championship 2028
- Court stops new Kano emirate law that allows Sanusi back
- Arsenal fans rejoice as two beloved former players met in Europa ...
- Transfer Centre LIVE! Burnley value Vincent Kompany at £17m amid ...